共 307 条
[1]
Adell A(2012)Is the acute NMDA receptor hypofunction a valid model of schizophrenia? Schizophr Bull 38 9-14
[2]
Jimenez-Sanchez L(2010)CB2: a cannabinoid receptor with an identity crisis Br J Pharmacol 160 467-479
[3]
Lopez-Gil X(2012)CB2 cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons Neuropharmacology 63 514-523
[4]
Romon T(2007)Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis Neuropsychopharmacology 32 2098-2107
[5]
Atwood BK(2013)Peripheral endocannabinoid system dysregulation in first-episode psychosis Neuropsychopharmacology 38 2568-2577
[6]
Mackie K(2011)AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents Psychopharmacology 215 149-163
[7]
Atwood BK(2011)Analytical data for identification of the cannabimimetic phenylacetylindole JWH-203 J Anal Toxicol 35 360-363
[8]
Straiker A(2001)Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies Psychopharmacology 156 234-258
[9]
Mackie K(2009)Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents Br J Pharmacol 157 844-853
[10]
Ballmaier M(2008)Ultrastructural localization of neuronal brain CB2 cannabinoid receptors Ann N Y Acad Sci 1139 450-457